Healthtech Startups

Sensaweb provides radiation monitoring technology, including a case study on improving visibility of radiation use and doses for a hospital isotope department serving radiation safety officers. It appears to serve healthcare and radiation safety settings.

1 investor

Sense Neuro Diagnostics is developing non-invasive technology to rapidly detect stroke subtype and traumatic brain injury and to continuously monitor brain injury, producing a scan in 2.5 seconds that analyzes the entire cranial vault. Its investigational device, NeuroHawk, is intended for medical personnel and is pending FDA De Novo review.

1 investor

Sense4Care develops wearable medical devices for movement disorder assessment, particularly Parkinson's Disease, using inertial measurement analysis. The company sells its STAT-ON product to hospitals, neurologists, and healthcare providers across Europe for objective symptom evaluation and disease management.

1 investor

An online retailer specializing in contact lenses from recognized manufacturers, offering daily, monthly, toric, and colored lenses selected by certified opticians. It serves consumers in France with features including a loyalty program, third-party payment (tiers payant), and fast delivery.

1 investor

Faeth Therapeutics is a biotech developing PIKTOR, an all-oral combination therapy that inhibits multiple nodes of the PAM (PI3K/AKT/mTOR) oncogenic pathway. It focuses on cancer treatments, with programs in endometrial cancer and HR+/HER2- breast cancer.

1 investor

Sensible Medical develops the ReDS system, a non-invasive monitoring technology that measures lung fluid levels in real-time to help clinicians manage heart failure and fluid-related conditions. The company serves healthcare providers and patients to reduce hospital readmissions and improve disease management.

1 investor

End-to-end online behavioral health provider.

1 investor

Sensible Care connects clients with licensed therapists and psychiatrists, offering insurance-based, often same-week appointments through a secure app to book sessions and track progress. It serves individuals in the U.S. seeking mental health care covered by major insurance providers.

1 investor

SensID GmbH develops and manufactures reference materials and quality controls for DNA diagnostics. The company serves laboratory and diagnostic instrument developers who need precisely characterized materials for research, validation, accreditation, and conformity testing.

1 investor

Sensill is developing a noninvasive, point-of-care diagnostic device that detects volatile organic compounds (VOCs) to identify and quantify bacteria and fungi, enabling clinicians to diagnose skin, wound, and urine infections and monitor treatment response in minutes. The portable, battery-operated system targets healthcare providers managing infections at the point of care.

1 investor

Sensimed SA develops the SENSIMED Triggerfish, a non-invasive soft contact lens-based device that automatically records continuous ocular dimensional changes over 24 hours to support glaucoma management. The company centralizes and analyzes this data on a registry to help ophthalmologists differentiate indications, personalize treatment, and assess treatment efficacy.

1 investor

Sensocure develops implantable microsensor technology to monitor tissue oxygen levels and detect ischemic events before irreversible damage occurs. The Norwegian medical device company targets clinical applications in tissue monitoring and prevention of ischemic injury.

1 investor

SENSOMATT develops intelligent systems combining IoT sensors, AI, and extended reality for elderly care, rehabilitation, and hospital settings. Its products include smart cushions and mattresses for pressure and fall detection, voice-based cognitive monitoring, and XR-based cognitive training platforms.

1 investor

SensorsCall offers carealert, a sensor-based device and dashboard system that passively monitors the wellness and daily activity of residents such as seniors without requiring input from patients or caregivers. It serves care facilities, remote social services, and medication compliance programs, providing activity trend alerts, intercom communication, and integration with FDA-approved health devices.

1 investor

eShift offers a real-time clinical care coordination platform that lets remote clinicians such as physicians, nurse practitioners, and registered nurses direct care for multiple patients while in-person team members like LPNs, CNAs, and paramedics deliver services at the point of care. The configurable system supports various clinical populations, care settings, and healthcare markets, with a focus on outcomes like hospital avoidance and lower cost per encounter.

1 investor

SensTek Diagnostics develops a solid-state molecular testing platform that enables rapid bacterial, fungal, and viral diagnostics across clinical, agricultural, water, and food safety applications. The company targets improved access to accurate diagnostics for communities underserved by traditional laboratory infrastructure.

1 investor

Sentante develops a robotic system for endovascular interventions that enables surgeons to remotely control guidewires and catheters with tactile feedback and real-time imaging. The platform serves interventional cardiologists, neurointerventionalists, and peripheral vascular specialists performing minimally invasive procedures.

1 investor

Sentinal4D develops interpretable machine learning tools for analyzing 3D and 4D cell morphology in drug discovery and mechanistic biology. PointMIL is a framework that classifies static 3D cell point clouds while providing point-level explanations of model predictions, enabling scientists to see where on the cell surface the model finds evidence for biological conclusions.

1 investor

Sentra is an AI-powered platform for post-acute care providers that automates clinical workflows such as referral processing to reduce administrative work and optimize financial outcomes. It targets healthcare organizations and facilities seeking faster, more accurate admissions decisions.

1 investor

1 investor

A biopharmaceutical company developing novel medicines for rare diseases, serving patients and caregivers from early detection through therapeutic intervention.

1 investor

Seonix develops a genetic risk score to identify individuals at elevated risk of glaucoma, serving eye health professionals, patients, and researchers. The company uses large-scale genetic datasets and advanced techniques for clinical risk prediction to help prevent vision loss.

1 investor

Sepsis Scout (formerly Patchd Medical) developed technology for sepsis detection, applying machine learning to physiological measurements in the medical device space. The company was acquired by Cytovale.

1 investor

Septest develops rapid point-of-need diagnostic tests for detecting infections and inflammation, including its multi-marker TRISEP test aimed at pre-hospital and community triage. The tools are intended for frontline healthcare professionals to speed sepsis detection and reduce antimicrobial resistance, with a focus on accessibility including in low- and middle-income countries.

1 investor